Roles of natural killer cells in antiviral immunity

Current Opinion in Virology

Volumn 16, Issue , 2016, Pages 15-23

  Waggoner, Stephen N ^a,b,c   Reighard, Seth D ^a,b,c   Gyurova, Ivayla E ^a,c   Cranert, Stacey A ^a   Mahl, Sarah E ^a   Karmele, Erik P ^a   McNally, Jonathan P ^a   Moran, Michael T ^a,b   Brooks, Taylor R ^a   Yaqoob, Fazeela ^a,b   Rydyznski, Carolyn E ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON;

ADAPTIVE IMMUNITY; ARTICLE; B LYMPHOCYTE; CELL KILLING; CYTOKINE RELEASE; DNA VIRUS; INNATE IMMUNITY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RNA VIRUS; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS IMMUNITY; VIRUS INFECTION; ANIMAL; CLASSIFICATION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; LYMPHOCYTE SUBPOPULATION; METABOLISM; VIROLOGY; VIRUS;

ADAPTIVE IMMUNITY; ANIMALS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; VIRUS DISEASES; VIRUSES;

EID: 84947080883     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2015.10.008     Document Type: Review

References (111)

1. R.M. Welsh, and S.N. Waggoner NK cells controlling virus-specific T cells: rheostats for acute vs. persistent infections Virology 435 2013 37 45
2. D.M. Andrews, M.J. Estcourt, C.E. Andoniou, M.E. Wikstrom, A. Khong, V. Voigt, P. Fleming, H. Tabarias, G.R. Hill, R.G. van der Most, and et al. Innate immunity defines the capacity of antiviral T cells to limit persistent infection J Exp Med 207 2010 1333 1343
3. G. Ferlazzo, B. Morandi, A. D'Agostino, R. Meazza, G. Melioli, A. Moretta, and L. Moretta The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells Eur J Immunol 33 2003 306 313
4. S.N. Waggoner, M. Cornberg, L.K. Selin, and R.M. Welsh Natural killer cells act as rheostats modulating antiviral T cells Nature 481 2012 394 398
5. D. Peppa, U.S. Gill, G. Reynolds, N.J. Easom, L.J. Pallett, A. Schurich, L. Micco, G. Nebbia, H.D. Singh, D.H. Adams, and et al. Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion J Exp Med 210 2013 99 114
6. N. Nielsen, N. Odum, B. Urso, L.L. Lanier, and P. Spee Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A PLoS One 7 2012 e31959
7. J. Crouse, G. Bedenikovic, M. Wiesel, M. Ibberson, I. Xenarios, D. Von Laer, U. Kalinke, E. Vivier, S. Jonjic, and A. Oxenius Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1 Immunity 40 2014 961 973
8. H.C. Xu, M. Grusdat, A.A. Pandyra, R. Polz, J. Huang, P. Sharma, R. Deenen, K. Kohrer, R. Rahbar, A. Diefenbach, and et al. Type I interferon protects antiviral CD8(+) T cells from NK cell cytotoxicity Immunity 40 2014 949 960
9. P.A. Lang, K.S. Lang, H.C. Xu, M. Grusdat, I.A. Parish, M. Recher, A.R. Elford, S. Dhanji, N. Shaabani, C.W. Tran, and et al. Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity Proc Natl Acad Sci U S A 109 2012 1210 1215
10. C. Cerboni, A. Zingoni, M. Cippitelli, M. Piccoli, L. Frati, and A. Santoni Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis Blood 110 2007 606 615
11. S.H. Lee, K.S. Kim, N. Fodil-Cornu, S.M. Vidal, and C.A. Biron Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection J Exp Med 206 2009 2235 2251
12. G. Perona-Wright, K. Mohrs, F.M. Szaba, L.W. Kummer, R. Madan, C.L. Karp, L.L. Johnson, S.T. Smiley, and M. Mohrs Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells Cell Host Microbe 6 2009 503 512
13. A. De Maria, M. Fogli, S. Mazza, M. Basso, A. Picciotto, P. Costa, S. Congia, M.C. Mingari, and L. Moretta Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients Eur J Immunol 37 2007 445 455
14. P. Krebs, M.J. Barnes, K. Lampe, K. Whitley, K.S. Bahjat, B. Beutler, E. Janssen, and K. Hoebe NK-cell-mediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses Blood 113 2009 6593 6602
15. J.C. Sun, J.N. Beilke, and L.L. Lanier Adaptive immune features of natural killer cells Nature 457 2009 557 561
16. S. Paust, H.S. Gill, B.Z. Wang, M.P. Flynn, E.A. Moseman, B. Senman, M. Szczepanik, A. Telenti, P.W. Askenase, R.W. Compans, and et al. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses Nat Immunol 11 2010 1127 1135
17. G.O. Gillard, M. Bivas-Benita, A.H. Hovav, L.E. Grandpre, M.W. Panas, M.S. Seaman, B.F. Haynes, and N.L. Letvin Thy1+ NK [corrected] cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytes PLoS Pathog 7 2011 e1002141
18. C.E. Rydyznski, and S.N. Waggoner Boosting vaccine efficacy the natural (killer) way Trends Immunol 36 2015 536 546
19. S. Jost, and M. Altfeld Control of human viral infections by natural killer cells Annu Rev Immunol 31 2013 163 194
20. G. Min-Oo, Y. Kamimura, D.W. Hendricks, T. Nabekura, and L.L. Lanier Natural killer cells: walking three paths down memory lane Trends Immunol 34 2013 251 258
21. J.S. Orange Natural killer cell deficiency J Allergy Clin Immunol 132 2013 515 525 quiz 526
22. J.F. Bukowski, B.A. Woda, S. Habu, K. Okumura, and R.M. Welsh Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo J Immunol 131 1983 1531 1538
23. A.A. Scalzo, N.A. Fitzgerald, C.R. Wallace, A.E. Gibbons, Y.C. Smart, R.C. Burton, and G.R. Shellam The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells J Immunol 149 1992 581 589
24. C.H. Tay, and R.M. Welsh Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells J Virol 71 1997 267 275
25. S. Jonjic, M. Babic, B. Polic, and A. Krmpotic Immune evasion of natural killer cells by viruses Curr Opin Immunol 20 2008 30 38
26. M. Luetke-Eversloh, Q. Hammer, P. Durek, K. Nordstrom, G. Gasparoni, M. Pink, A. Hamann, J. Walter, H.D. Chang, J. Dong, and et al. Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells PLoS Pathog 10 2014 e1004441
27. J. Lee, T. Zhang, I. Hwang, A. Kim, L. Nitschke, M. Kim, J.M. Scott, Y. Kamimura, L.L. Lanier, and S. Kim Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals Immunity 42 2015 431 442
28. H. Schlums, F. Cichocki, B. Tesi, J. Theorell, V. Beziat, T.D. Holmes, H. Han, S.C. Chiang, B. Foley, K. Mattsson, and et al. Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function Immunity 42 2015 443 456
29. M. Guma, A. Angulo, C. Vilches, N. Gomez-Lozano, N. Malats, and M. Lopez-Botet Imprint of human cytomegalovirus infection on the NK cell receptor repertoire Blood 104 2004 3664 3671
30. V. Beziat, L.L. Liu, J.A. Malmberg, M.A. Ivarsson, E. Sohlberg, A.T. Bjorklund, C. Retiere, E. Sverremark-Ekstrom, J. Traherne, P. Ljungman, and et al. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs Blood 121 2013 2678 2688
31. H.C. Su, K.B. Nguyen, T.P. Salazar-Mather, M.C. Ruzek, M.Y. Dalod, and C.A. Biron NK cell functions restrain T cell responses during viral infections Eur J Immunol 31 2001 3048 3055
32. S.H. Robbins, G. Bessou, A. Cornillon, N. Zucchini, B. Rupp, Z. Ruzsics, T. Sacher, E. Tomasello, E. Vivier, U.H. Koszinowski, and et al. Natural killer cells promote early CD8 T cell responses against cytomegalovirus PLoS Pathog 3 2007 e123
33. M.D. Stadnisky, X. Xie, E.R. Coats, T.N. Bullock, and M.G. Brown Self MHC class I-licensed NK cells enhance adaptive CD8 T-cell viral immunity Blood 117 2011 5133 5141
34. M. Mitrovic, J. Arapovic, S. Jordan, N. Fodil-Cornu, S. Ebert, S.M. Vidal, A. Krmpotic, M.J. Reddehase, and S. Jonjic The NK cell response to mouse cytomegalovirus infection affects the level and kinetics of the early CD8+ T-cell response J Virol 86 2012 2165 2175
35. F.E. Sepulveda, S. Maschalidi, C.A. Vosshenrich, A. Garrigue, M. Kurowska, G. Menasche, A. Fischer, J.P. Di Santo, and G. de Saint Basile A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice Blood 125 2015 1427 1434
36. I.S. Schuster, M.E. Wikstrom, G. Brizard, J.D. Coudert, M.J. Estcourt, M. Manzur, L.A. O'Reilly, M.J. Smyth, J.A. Trapani, G.R. Hill, and et al. TRAIL+ NK cells control CD4+ T cell responses during chronic viral infection to limit autoimmunity Immunity 41 2014 646 656
37. O. Chijioke, A. Muller, R. Feederle, M.H. Barros, C. Krieg, V. Emmel, E. Marcenaro, C.S. Leung, O. Antsiferova, V. Landtwing, and et al. Human natural killer cells prevent infectious mononucleosis features by targeting lytic epstein-barr virus infection Cell Rep 5 2013 1489 1498
38. Q.U. Kamili, F.O. Seeborg, K. Saxena, S.K. Nicholas, P.P. Banerjee, L.S. Angelo, E.M. Mace, L.R. Forbes, C. Martinez, T.S. Wright, and et al. Severe cutaneous human papillomavirus infection associated with natural killer cell deficiency following stem cell transplantation for severe combined immunodeficiency J Allergy Clin Immunol 134 2014 1451 1453 e1451
39. I. Langers, V. Renoux, A. Reschner, A. Touze, P. Coursaget, J. Boniver, J. Koch, P. Delvenne, and N. Jacobs Natural killer and dendritic cells collaborate in the immune response induced by the vaccine against uterine cervical cancer Eur J Immunol 44 2014 3585 3595
40. Y. Bauman, D. Nachmani, A. Vitenshtein, P. Tsukerman, N. Drayman, N. Stern-Ginossar, D. Lankry, R. Gruda, and O. Mandelboim An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination Cell Host Microbe 9 2011 93 102
41. R. Mishra, A.T. Chen, R.M. Welsh, and E. Szomolanyi-Tsuda NK cells and gammadelta T cells mediate resistance to polyomavirus-induced tumors PLoS Pathog 6 2010 e1000924
42. R. Mishra, B. Polic, R.M. Welsh, and E. Szomolanyi-Tsuda Inflammatory cytokine-mediated evasion of virus-induced tumors from NK cell control J Immunol 191 2013 961 970
43. M.L. Delano, and D.G. Brownstein Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype J Virol 69 1995 5875 5877
44. A.K. Parker, S. Parker, W.M. Yokoyama, J.A. Corbett, and R.M. Buller Induction of natural killer cell responses by ectromelia virus controls infection J Virol 81 2007 4070 4079
45. M. Fang, L.L. Lanier, and L.J. Sigal A role for NKG2D in NK cell-mediated resistance to poxvirus disease PLoS Pathog 4 2008 e30
46. T.L. Born, L.A. Morrison, D.J. Esteban, T. VandenBos, L.G. Thebeau, N. Chen, M.K. Spriggs, J.E. Sims, and R.M. Buller A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response J Immunol 164 2000 3246 3254
47. N. Jacobs, N.W. Bartlett, R.H. Clark, and G.L. Smith Vaccinia virus lacking the Bcl-2-like protein N1 induces a stronger natural killer cell response to infection J Gen Virol 89 2008 2877 2881
48. C.R. Melo-Silva, D.C. Tscharke, M. Lobigs, A. Koskinen, Y.C. Wong, R.M. Buller, A. Mullbacher, and M. Regner The ectromelia virus SPI-2 protein causes lethal mousepox by preventing NK cell responses J Virol 85 2011 11170 11182
49. N. Yawata, K.J. Selva, Y.C. Liu, K.P. Tan, A.W. Lee, J. Siak, W. Lan, M. Vania, A. Arundhati, L. Tong, and et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection Mucosal Immunol 2015 10.1038/mi.2015.47 (epub ahead of print)
50. B.P. McSharry, H.G. Burgert, D.P. Owen, R.J. Stanton, V. Prod'homme, M. Sester, K. Koebernick, V. Groh, T. Spies, S. Cox, and et al. Adenovirus E3/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A and B J Virol 82 2008 4585 4594
51. Z.X. Liu, S. Govindarajan, S. Okamoto, and G. Dennert NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection J Immunol 164 2000 6480 6486
52. M.C. Ruzek, B.F. Kavanagh, A. Scaria, S.M. Richards, and R.D. Garman Adenoviral vectors stimulate murine natural killer cell responses and demonstrate antitumor activities in the absence of transgene expression Mol Ther 5 2002 115 124
53. J. Zhu, X. Huang, and Y. Yang A critical role for type I IFN-dependent NK cell activation in innate immune elimination of adenoviral vectors in vivo Mol Ther 16 2008 1300 1307
54. S. Lunemann, D.F. Malone, J. Hengst, K. Port, J. Grabowski, K. Deterding, A. Markova, B. Bremer, V. Schlaphoff, M. Cornberg, and et al. Compromised function of natural killer cells in acute and chronic viral hepatitis J Infect Dis 209 2014 1362 1373
55. Y. Ju, N. Hou, J. Meng, X. Wang, X. Zhang, D. Zhao, Y. Liu, F. Zhu, L. Zhang, W. Sun, and et al. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B J Hepatol 52 2010 322 329
56. A. Schuch, A. Hoh, and R. Thimme The role of natural killer cells and CD8(+) T cells in hepatitis B virus infection Front Immunol 5 2014 258
57. B. Rehermann Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells Nat Med 19 2013 859 868
58. R.M. Welsh, C.L. O'Donnell, and L.D. Shultz Antiviral activity of NK 1.1+ natural killer cells in C57BL/6 scid mice infected with murine cytomegalovirus Nat Immun 13 1994 239 245
59. S.N. Waggoner, R.T. Taniguchi, P.A. Mathew, V. Kumar, and R.M. Welsh Absence of mouse 2B4 promotes NK cell-mediated killing of activated CD8+ T cells, leading to prolonged viral persistence and altered pathogenesis J Clin Invest 120 2010 1925 1938
60. K.D. Cook, and J.K. Whitmire The depletion of NK cells prevents T cell exhaustion to efficiently control disseminating virus infection J Immunol 190 2013 641 649
61. K.D. Cook, H.C. Kline, and J.K. Whitmire NK cells inhibit humoral immunity by reducing the abundance of CD4+ T follicular helper cells during a chronic virus infection J Leukoc Biol 98 2015 153 162
62. C. Rydyznski, K.A. Daniels, E.P. Karmele, T.R. Brooks, S.E. Mahl, M.T. Moran, C. Li, R. Sutiwisesak, R.M. Welsh, and S.N. Waggoner Generation of cellular immune memory and B-cell immunity is impaired by natural killer cells Nat Commun 6 2015 6375
63. M. Russier, S. Reynard, X. Carnec, and S. Baize The exonuclease domain of Lassa virus nucleoprotein is involved in antigen-presenting-cell-mediated NK cell responses J Virol 88 2014 13811 13820
64. E. Muyanja, A. Ssemaganda, P. Ngauv, R. Cubas, H. Perrin, D. Srinivasan, G. Canderan, B. Lawson, J. Kopycinski, A.S. Graham, and et al. Immune activation alters cellular and humoral responses to yellow fever 17D vaccine J Clin Invest 124 2014 3147 3158
65. T. Wang, and T. Welte Role of natural killer and Gamma-delta T cells in West Nile virus infection Viruses 5 2013 2298 2310
66. C. Petitdemange, N. Wauquier, J. Rey, B. Hervier, E. Leroy, and V. Vieillard Control of acute dengue virus infection by natural killer cells Front Immunol 5 2014 209
67. J. Stein-Streilein, and J. Guffee In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection J Immunol 136 1986 1435 1441
68. A. Glasner, A. Zurunic, T. Meningher, T. Lenac Rovis, P. Tsukerman, Y. Bar-On, R. Yamin, A.F. Meyers, M. Mandeboim, S. Jonjic, and et al. Elucidating the mechanisms of influenza virus recognition by Ncr1 PLoS One 7 2012 e36837
69. R. Gazit, R. Gruda, M. Elboim, T.I. Arnon, G. Katz, H. Achdout, J. Hanna, U. Qimron, G. Landau, E. Greenbaum, and et al. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1 Nat Immunol 7 2006 517 523
70. Y. Dou, B. Fu, R. Sun, W. Li, W. Hu, Z. Tian, and H. Wei Influenza vaccine induces intracellular immune memory of human NK cells PLoS One 10 2015 e0121258
71. M.Q. Ge, A.W. Ho, Y. Tang, K.H. Wong, B.Y. Chua, S. Gasser, and D.M. Kemeny NK cells regulate CD8+ T cell priming and dendritic cell migration during influenza A infection by IFN-gamma and perforin-dependent mechanisms J Immunol 189 2012 2099 2109
72. F. Li, H. Zhu, R. Sun, H. Wei, and Z. Tian Natural killer cells are involved in acute lung immune injury caused by respiratory syncytial virus infection J Virol 86 2012 2251 2258
73. J.S. Tregoning, B.L. Wang, J.U. McDonald, Y. Yamaguchi, J.A. Harker, M. Goritzka, C. Johansson, A. Bukreyev, P.L. Collins, and P.J. Openshaw Neonatal antibody responses are attenuated by interferon-gamma produced by NK and T cells during RSV infection Proc Natl Acad Sci U S A 110 2013 5576 5581
74. N. Wauquier, C. Padilla, P. Becquart, E. Leroy, and V. Vieillard Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection Immunogenetics 62 2010 767 771
75. C.L. Fuller, G. Ruthel, K.L. Warfield, D.L. Swenson, C.M. Bosio, M.J. Aman, and S. Bavari NKp30-dependent cytolysis of filovirus-infected human dendritic cells Cell Microbiol 9 2007 962 976
76. K.L. Warfield, J.G. Perkins, D.L. Swenson, E.M. Deal, C.M. Bosio, M.J. Aman, W.M. Yokoyama, H.A. Young, and S. Bavari Role of natural killer cells in innate protection against lethal ebola virus infection J Exp Med 200 2004 169 179
77. K.J. Williams, X. Qiu, L. Fernando, S.M. Jones, and J.B. Alimonti VSVDeltaG/EBOV GP-induced innate protection enhances natural killer cell activity to increase survival in a lethal mouse adapted Ebola virus infection Viral Immunol 28 2015 51 61
78. L.B. Cook, M. Elemans, A.G. Rowan, and B. Asquith HTLV-1: persistence and pathogenesis Virology 435 2013 131 140
79. A.A. Bashirova, R. Thomas, and M. Carrington HLA/KIR restraint of HIV: surviving the fittest Annu Rev Immunol 29 2011 295 317
80. G. Alter, M.P. Martin, N. Teigen, W.H. Carr, T.J. Suscovich, A. Schneidewind, H. Streeck, M. Waring, A. Meier, C. Brander, and et al. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes J Exp Med 204 2007 3027 3036
81. G. Alter, D. Heckerman, A. Schneidewind, L. Fadda, C.M. Kadie, J.M. Carlson, C. Oniangue-Ndza, M. Martin, B. Li, S.I. Khakoo, and et al. HIV-1 adaptation to NK-cell-mediated immune pressure Nature 476 2011 96 100
82. A.H. Shah, B. Sowrirajan, Z.B. Davis, J.P. Ward, E.M. Campbell, V. Planelles, and E. Barker Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu Cell Host Microbe 8 2010 397 409
83. G. Matusali, M. Potesta, A. Santoni, C. Cerboni, and M. Doria The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR J Virol 86 2012 4496 4504
84. A. Nolting, A.S. Dugast, S. Rihn, R. Luteijn, M.F. Carrington, K. Kane, S. Jost, I. Toth, E. Nagami, G. Faetkenheuer, and et al. MHC class I chain-related protein A shedding in chronic HIV-1 infection is associated with profound NK cell dysfunction Virology 406 2010 12 20
85. S. Kulkarni, R. Savan, Y. Qi, X. Gao, Y. Yuki, S.E. Bass, M.P. Martin, P. Hunt, S.G. Deeks, A. Telenti, and et al. Differential microRNA regulation of HLA-C expression and its association with HIV control Nature 472 2011 495 498
86. M.P. Martin, Y. Qi, X. Gao, E. Yamada, J.N. Martin, F. Pereyra, S. Colombo, E.E. Brown, W.L. Shupert, J. Phair, and et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1 Nat Genet 39 2007 733 740
87. C. Tomescu, F.M. Duh, R. Hoh, A. Viviani, K. Harvill, M.P. Martin, M. Carrington, S.G. Deeks, and L.J. Montaner Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers AIDS 26 2012 1869 1878
88. E. Littwitz, S. Francois, U. Dittmer, and K. Gibbert Distinct roles of NK cells in viral immunity during different phases of acute Friend retrovirus infection Retrovirology 10 2013 127
89. E. Littwitz-Salomon, I. Akhmetzyanova, C. Vallet, S. Francois, U. Dittmer, and K. Gibbert Activated regulatory T cells suppress effector NK cell responses by an IL-2-mediated mechanism during an acute retroviral infection Retrovirology 12 2015 66
90. Y. Takahashi, A.E. Mayne, L. Khowawisetsut, K. Pattanapanyasat, D. Little, F. Villinger, and A.A. Ansari In vivo administration of a JAK3 inhibitor to chronically siv infected rhesus macaques leads to NK cell depletion associated with transient modest increase in viral loads PLoS One 8 2013 e70992
91. J.L. Schafer, H. Li, T.I. Evans, J.D. Estes, and R.K. Reeves Accumulation of cytotoxic CD16+ NK cells in simian immunodeficiency virus-infected lymph nodes associated with in situ differentiation and functional anergy J Virol 89 2015 6887 6894
92. J.L. Schafer, M. Ries, N. Guha, M. Connole, A.D. Colantonio, E.J. Wiertz, N.A. Wilson, A. Kaur, and D.T. Evans Suppression of a natural killer cell response by simian immunodeficiency virus peptides PLoS Pathog 11 2015 e1005145
93. C. Albrecht, D. Malzahn, M. Brameier, M. Hermes, A.A. Ansari, and L. Walter Progression to AIDS in SIV-infected rhesus macaques is associated with distinct KIR and MHC class I polymorphisms and NK cell dysfunction Front Immunol 5 2014 600
94. R.K. Reeves, H. Li, S. Jost, E. Blass, H. Li, J.L. Schafer, V. Varner, C. Manickam, L. Eslamizar, M. Altfeld, and et al. Antigen-specific NK cell memory in rhesus macaques Nat Immunol 16 2015 927 932
95. J.F. Lima, L.M. Oliveira, N.Z. Pereira, G.E. Mitsunari, A.J. Duarte, and M.N. Sato Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56(dim) and CD56(bright) cells and memory-like CD57(+)NKG2C(+)CD56(dim) cells J Acquir Immune Defic Syndr 67 2014 463 471
96. G.N. Barber Vesicular stomatitis virus as an oncolytic vector Viral Immunol 17 2004 516 527
97. J. Altomonte, L. Wu, M. Meseck, L. Chen, O. Ebert, A. Garcia-Sastre, J. Fallon, J. Mandeli, and S.L. Woo Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cells Cancer Gene Ther 16 2009 266 278
98. C.A. Alvarez-Breckenridge, J. Yu, R. Price, J. Wojton, J. Pradarelli, H. Mao, M. Wei, Y. Wang, S. He, J. Hardcastle, and et al. NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors Nat Med 18 2012 1827 1834
99. T. Granot, L. Venticinque, J.C. Tseng, and D. Meruelo Activation of cytotoxic and regulatory functions of NK cells by Sindbis viral vectors PLoS One 6 2011 e20598
100. N.K. Bjorkstrom, T. Lindgren, M. Stoltz, C. Fauriat, M. Braun, M. Evander, J. Michaelsson, K.J. Malmberg, J. Klingstrom, C. Ahlm, and et al. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus J Exp Med 208 2011 13 21
101. E.K. Godeny, and C.J. Gauntt Murine natural killer cells limit coxsackievirus B3 replication J Immunol 139 1987 913 918
102. H.I. McFarland, and N.J. Bigley Sex-dependent, early cytokine production by NK-like spleen cells following infection with the D variant of encephalomyocarditis virus (EMCV-D) Viral Immunol 2 1989 205 214
103. C.V. Paya, A.K. Patick, P.J. Leibson, and M. Rodriguez Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus J Immunol 143 1989 95 102
104. Y. Zou, T. Chen, M. Han, H. Wang, W. Yan, G. Song, Z. Wu, X. Wang, C. Zhu, X. Luo, and et al. Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure J Immunol 184 2010 466 475
105. R.M. Welsh, M.V. Haspel, D.C. Parker, and K.V. Holmes Natural cytotoxicity against mouse hepatitis virus-infected cells II. A cytotoxic effector cell with a B lymphocyte phenotype J Immunol 136 1986 1454 1460
106. D.A. Vargas-Inchaustegui, P. Xiao, T. Demberg, R. Pal, and M. Robert-Guroff Therapeutic envelope vaccination in combination with antiretroviral therapy temporarily rescues SIV-specific CD4(+) T-cell-dependent natural killer cell effector responses in chronically infected rhesus macaques Immunology 145 2015 288 299
107. S. Jost, P.J. Tomezsko, K. Rands, I. Toth, M. Lichterfeld, R.T. Gandhi, and M. Altfeld CD4+ T-cell help enhances NK cell function following therapeutic HIV-1 vaccination J Virol 88 2014 8349 8354
108. J.M. Werner, E. Serti, X. Chepa-Lotrea, J. Stoltzfus, G. Ahlenstiel, M. Noureddin, J.J. Feld, T.J. Liang, Y. Rotman, and B. Rehermann Ribavirin improves the IFN-gamma response of natural killer cells to IFN-based therapy of hepatitis C virus infection Hepatology 60 2014 1160 1169
109. K. Seay, C. Church, J.H. Zheng, K. Deneroff, C. Ochsenbauer, J.C. Kappes, B. Liu, E.K. Jeng, H.C. Wong, and H. Goldstein In vivo activation of human NK cells by treatment with an interleukin-15 superagonist potently inhibits acute in vivo HIV-1 infection in humanized mice J Virol 89 2015 6264 6274
110. T. Kawahara, T. Takahashi, K. Oishi, H. Tanaka, M. Masuda, S. Takahashi, M. Takano, T. Kawakami, K. Fukushima, H. Kanazawa, and et al. Consecutive oral administration of Bifidobacterium longum MM-2 improves the defense system against influenza virus infection by enhancing natural killer cell activity in a murine model Microbiol Immunol 59 2015 1 12
111. S.N. Waggoner, K.A. Daniels, and R.M. Welsh Therapeutic depletion of natural killer cells controls persistent infection J Virol 88 2014 1953 1960